These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 6369113

  • 1. Is the membrane attack complex of complement an enzyme?
    Boyle MD.
    Mol Cell Biochem; 1984; 61(1):5-15. PubMed ID: 6369113
    [Abstract] [Full Text] [Related]

  • 2. The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.
    Schönermark S, Filsinger S, Berger B, Hänsch GM.
    Immunology; 1988 Apr; 63(4):585-90. PubMed ID: 3366469
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
    Rosenfeld SI, Packman CH, Leddy JP.
    J Clin Invest; 1983 Apr; 71(4):795-808. PubMed ID: 6403580
    [Abstract] [Full Text] [Related]

  • 4. Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice.
    Fu X, Ju J, Lin Z, Xiao W, Li X, Zhuang B, Zhang T, Ma X, Li X, Ma C, Su W, Wang Y, Qin X, Liang S.
    Sci Rep; 2016 Jul 22; 6():30239. PubMed ID: 27444648
    [Abstract] [Full Text] [Related]

  • 5. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9.
    Carney DF, Koski CL, Shin ML.
    J Immunol; 1985 Mar 22; 134(3):1804-9. PubMed ID: 3968432
    [Abstract] [Full Text] [Related]

  • 6. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH, Abramovitz AS, Mayer MM.
    J Immunol; 1976 Sep 22; 117(3):830-4. PubMed ID: 956655
    [Abstract] [Full Text] [Related]

  • 7. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
    Meri S, Morgan BP, Davies A, Daniels RH, Olavesen MG, Waldmann H, Lachmann PJ.
    Immunology; 1990 Sep 22; 71(1):1-9. PubMed ID: 1698710
    [Abstract] [Full Text] [Related]

  • 8. Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes.
    Fernie-King BA, Seilly DJ, Willers C, Würzner R, Davies A, Lachmann PJ.
    Immunology; 2001 Jul 22; 103(3):390-8. PubMed ID: 11454069
    [Abstract] [Full Text] [Related]

  • 9. Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass.
    Salama A, Hugo F, Heinrich D, Höge R, Müller R, Kiefel V, Mueller-Eckhardt C, Bhakdi S.
    N Engl J Med; 1988 Feb 18; 318(7):408-14. PubMed ID: 3340119
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA, Zhao J, Ninomiya H, Sims PJ.
    J Immunol; 1991 Apr 01; 146(7):2345-51. PubMed ID: 1706395
    [Abstract] [Full Text] [Related]

  • 11. Glycophorin A inhibits lysis by the complement attack phase.
    Brauch H, Roelcke D, Rother U.
    Immunobiology; 1983 Aug 01; 165(2):115-20. PubMed ID: 6629410
    [Abstract] [Full Text] [Related]

  • 12. The membrane attack complex.
    Müller-Eberhard HJ.
    Springer Semin Immunopathol; 1984 Aug 01; 7(2-3):93-141. PubMed ID: 6387983
    [No Abstract] [Full Text] [Related]

  • 13. Suppression of the anti-erythrocyte immune response in mice by the C5b--9 complex of complement.
    Horn W, Opferkuch W, Podack ER.
    Immunology; 1981 Jun 01; 43(2):303-9. PubMed ID: 7019052
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of complement-induced cell lysis. Demonstration of a three-step mechanism of EAC1-8 cell lysis by C9 and of a non-osmotic swelling of erythrocytes.
    Valet G, Opferkuch W.
    J Immunol; 1975 Oct 01; 115(4):1028-33. PubMed ID: 809505
    [Abstract] [Full Text] [Related]

  • 15. Membrane vesiculation protects erythrocytes from destruction by complement.
    Iida K, Whitlow MB, Nussenzweig V.
    J Immunol; 1991 Oct 15; 147(8):2638-42. PubMed ID: 1918984
    [Abstract] [Full Text] [Related]

  • 16. Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process.
    Kim SH, Carney DF, Hammer CH, Shin ML.
    J Immunol; 1987 Mar 01; 138(5):1530-6. PubMed ID: 2433349
    [Abstract] [Full Text] [Related]

  • 17. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH, Rosenfeld SI, Jenkins DE, Thiem PA, Leddy JP.
    J Clin Invest; 1979 Aug 01; 64(2):428-33. PubMed ID: 457861
    [Abstract] [Full Text] [Related]

  • 18. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI, Jenkins DE, Leddy JP.
    J Immunol; 1985 Jan 01; 134(1):506-11. PubMed ID: 3964820
    [Abstract] [Full Text] [Related]

  • 19. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L, Morris CA, Sheehan MC, Charlesworth JA, Pussell BA.
    Clin Exp Immunol; 1993 Apr 01; 92(1):114-9. PubMed ID: 7682159
    [Abstract] [Full Text] [Related]

  • 20. Neoantigens of the membrane attack complex of human complement.
    Kolb WP, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1975 May 01; 72(5):1687-9. PubMed ID: 51500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.